Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The DDAH/ADMA/NOS pathway.

Cam T L Tran1, James M Leiper, Patrick Vallance

  • 1Centre for Clinical Pharmacology and Therapeutics, BHF Laboratories, Division of Medicine, University College London, 5 University Street, London, WC1E 6JJ, UK.

Atherosclerosis. Supplements
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal motor evoked potential decomposition reveals that cortico-reticulospinal excitability is increased in athletes with patellar tendinopathy - Preliminary evidence of compensatory adaptation for diminished motor drive.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2026
Same author

Greater endogenous pain facilitation is associated with lower spinal excitability and maximal knee extension strength deficits in athletes with patellar tendinopathy.

European journal of applied physiology·2026
Same author

Neural deficits relevant to pain symptoms and functional impairments in individuals with Achilles or patellar tendinopathy (PhD Academy Award).

British journal of sports medicine·2025
Same author

Transcranial magnetic stimulation and electrical stimulation techniques used to measure the excitability of distinct neuronal populations that influence motor output in people with persistent musculoskeletal conditions: A scoping review and narrative synthesis of evidence.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2025
Same author

Response letter: The only defendable scientific position: A strong case against radial extracorporeal shockwave therapy for insertional Achilles tendinopathy.

Clinical rehabilitation·2025
Same author

Endogenous pain modulation is not different in basketball or volleyball athletes with patellar tendinopathy compared to asymptomatic athletic controls.

Musculoskeletal science & practice·2025
Same journal

'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.

Atherosclerosis. Supplements·2021
Same journal

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool.

Atherosclerosis. Supplements·2021
Same journal

Lipid Clinics Network. Rationale and design of the EAS global project.

Atherosclerosis. Supplements·2021
Same journal

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.

Atherosclerosis. Supplements·2021
Same journal

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.

Atherosclerosis. Supplements·2021
Same journal

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.

Atherosclerosis. Supplements·2021
See all related articles

Dimethylarginine dimethylaminohydrolase (DDAH) enzymes metabolize asymmetric dimethylarginine (ADMA), a key inhibitor of nitric oxide synthase (NOS). DDAH activity is crucial for regulating ADMA levels and nitric oxide generation in various diseases.

Area of Science:

  • Biochemistry
  • Physiology
  • Molecular Biology

Background:

  • Endogenously produced inhibitors, such as asymmetric dimethylarginine (ADMA), regulate nitric oxide synthase (NOS) activity.
  • ADMA plays a significant role in various disease states by modulating nitric oxide (NO) generation.
  • Two dimethylarginine dimethylaminohydrolase (DDAH) enzymes are responsible for metabolizing ADMA.

Purpose of the Study:

  • To review recent advances in the understanding of DDAH enzyme regulation and function.
  • To elucidate the role of DDAH enzymes in controlling ADMA levels in vivo.
  • To highlight the significance of DDAH in the regulation of nitric oxide generation.

Main Methods:

  • Literature review of recent studies on DDAH enzymes.
  • Analysis of data on DDAH regulation and function.

Related Experiment Videos

  • Synthesis of information regarding DDAH's role in NO metabolism.

    • Main Results:

    • DDAH enzyme activity is a key determinant of ADMA levels in vivo.
    • Advances in understanding DDAH regulation provide insights into NO homeostasis.
    • The function of DDAH is critical for modulating ADMA-mediated inhibition of NOS.

    Conclusions:

    • DDAH enzymes are central regulators of ADMA metabolism and, consequently, nitric oxide generation.
    • Understanding DDAH function is vital for developing therapeutic strategies targeting diseases associated with NO dysregulation.
    • Further research into DDAH regulation will enhance our knowledge of NO bioavailability in health and disease.